UBS ASSET MANAGEMENT AMERICAS INC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$9,673,670,000
-80.4%
63,992
-81.1%
0.01%
-80.8%
Q2 2022$49,354,016,000
+586.7%
338,714
+458.8%
0.03%
+766.7%
Q1 2022$7,187,239,000
-7.5%
60,616
+7.5%
0.00%0.0%
Q4 2021$7,769,314,000
+1.8%
56,377
+2.7%
0.00%0.0%
Q3 2021$7,628,521,000
+44.6%
54,917
+1.0%
0.00%
+50.0%
Q2 2021$5,276,687,000
+48.2%
54,354
+4.3%
0.00%0.0%
Q1 2021$3,561,708,000
-16.2%
52,103
+5.1%
0.00%0.0%
Q4 2020$4,249,930,000
+45.4%
49,585
+10.3%
0.00%0.0%
Q3 2020$2,922,720,000
-10.5%
44,958
+0.6%
0.00%0.0%
Q2 2020$3,266,189,000
+87.8%
44,675
-12.6%
0.00%
+100.0%
Q1 2020$1,739,615,000
-40.2%
51,120
-4.3%
0.00%
-50.0%
Q4 2019$2,907,368,000
-64.0%
53,405
-72.4%
0.00%
-60.0%
Q3 2019$8,083,583,000
+3.2%
193,758
+8.4%
0.01%
-16.7%
Q2 2019$7,830,352,000
+2101.0%
178,816
+2487.0%
0.01%
Q1 2019$355,761,000
+39.2%
6,9120.0%0.00%
Q4 2018$255,606,000
+3.1%
6,912
+4.7%
0.00%
Q3 2018$247,830,0006,6000.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2020
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders